Company Filing History:
Years Active: 2021
Title: Kosta Panousis: Innovator in CD131 Binding Proteins
Introduction
Kosta Panousis is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of proteins that interact with specific cellular pathways.
Latest Patents
Kosta holds a patent for CD131 binding proteins. This patent describes a CD131-binding protein that comprises an antigen binding domain of an antibody. The antigen binding domain specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5, and granulocyte-macrophage colony stimulating factor (GM-CSF). This innovation has potential applications in therapeutic settings.
Career Highlights
Kosta is currently employed at CSL Limited, a global biotechnology company known for its innovative medicines. His work at CSL Limited focuses on advancing therapeutic solutions that address critical health challenges.
Collaborations
Kosta collaborates with talented professionals in his field, including Catherine Owczarek and Nicholas Wilson. Their combined expertise contributes to the success of their projects and innovations.
Conclusion
Kosta Panousis is a distinguished inventor whose work on CD131 binding proteins exemplifies the impact of biotechnology on healthcare. His contributions continue to pave the way for future advancements in the field.